Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025)
Talphera (TLPH) posted quarterly Net Income towards Common Stockholders of $73000.0 for Q1 2025, up 101.62% quarter-over-quarter from -$4.5 million in Q4 2023.
Talphera (TLPH) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Talphera's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $73000.0 for Q1 2025.
- In Q1 2025, Net Income towards Common Stockholders changed N/A year-over-year to $73000.0; the TTM figure through Dec 2025 stood at $73000.0 (changed N/A YoY), while the FY2025 annual figure was $73000.0, changed N/A from the prior year.
- Net Income towards Common Stockholders for Q1 2025 stood at $73000.0, up from -$4.5 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $63.2 million in Q2 2022, with the low at -$9.9 million in Q2 2021.
- The 4-year median for Net Income towards Common Stockholders is -$4.5 million (2023), against an average of $698076.9.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders surged 741.07% in 2022, then sank 106.92% in 2023.
- Talphera's Net Income towards Common Stockholders stood at -$7.9 million in 2021, then surged by 34.37% to -$5.2 million in 2022, then rose by 13.3% to -$4.5 million in 2023, then soared by 101.62% to $73000.0 in 2025.
- Business Quant data shows TLPH's Net Income towards Common Stockholders at $73000.0 in Q1 2025, -$4.5 million in Q4 2023, and -$1.4 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 710.19 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | -3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2023 | -4.51 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | -4.37 Mn |
| Mar 31, 2023 | 8.22 Mn |
| Dec 31, 2022 | -5.20 Mn |
| Sep 30, 2022 | -6.94 Mn |
| Jun 30, 2022 | 63.15 Mn |
| Mar 31, 2022 | -4.06 Mn |
| Dec 31, 2021 | -7.92 Mn |
| Sep 30, 2021 | -8.38 Mn |
| Jun 30, 2021 | -9.85 Mn |
| Mar 31, 2021 | -9.74 Mn |
| Dec 31, 2020 | -8.92 Mn |
| Sep 30, 2020 | -8.93 Mn |
| Jun 30, 2020 | -6.61 Mn |
| Mar 31, 2020 | -16.77 Mn |
| Dec 31, 2019 | -14.42 Mn |
| Sep 30, 2019 | -12.73 Mn |
| Jun 30, 2019 | -12.41 Mn |